Ofloxacin ophthalmic is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Altaire Pharmaceuticals Inc.. The primary component is Ofloxacin.
Product ID | 59390-140_28125c1a-d1b0-4763-9b5e-07b4cfc2d889 |
NDC | 59390-140 |
Product Type | Human Prescription Drug |
Proprietary Name | Ofloxacin ophthalmic |
Generic Name | Ofloxacin |
Dosage Form | Solution |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2013-05-31 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202692 |
Labeler Name | Altaire Pharmaceuticals Inc. |
Substance Name | OFLOXACIN |
Active Ingredient Strength | 3 mg/mL |
Pharm Classes | Quinolone Antimicrobial [EPC], Quinolones [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2013-05-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202692 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-05-31 |
Ingredient | Strength |
---|---|
OFLOXACIN | 3 mg/mL |
SPL SET ID: | fe564e33-8f5d-4b57-87a9-7afae02eaf97 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59390-140 | Ofloxacin ophthalmic | Ofloxacin ophthalmic |
11980-779 | OCUFLOX | ofloxacin |
0404-7189 | Ofloxacin | Ofloxacin |
0517-0760 | Ofloxacin | Ofloxacin |
13985-602 | Ofloxacin | Ofloxacin |
17478-713 | Ofloxacin | Ofloxacin |
21695-439 | Ofloxacin | Ofloxacin |
24208-410 | Ofloxacin | Ofloxacin |
24208-434 | Ofloxacin | Ofloxacin |
33261-737 | Ofloxacin | Ofloxacin |
40042-049 | Ofloxacin | Ofloxacin |
42254-257 | Ofloxacin | Ofloxacin |
50090-0891 | Ofloxacin | Ofloxacin |
50090-1346 | Ofloxacin | Ofloxacin |
50090-1736 | Ofloxacin | Ofloxacin |
50090-5186 | Ofloxacin | ofloxacin |
50090-5209 | Ofloxacin | ofloxacin |
50090-5210 | Ofloxacin | ofloxacin |
50090-5425 | Ofloxacin | Ofloxacin |
50383-024 | Ofloxacin | Ofloxacin |
50090-1090 | Ofloxacin Otic | Ofloxacin |